Abel Hall »

Tg Therapeutics shares owned by Abel Hall

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Abel Hall from 13F filings

Historical chart of Abel Hall investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Abel Hall consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Abel Hall

Quarter filed Position value Share count Share price at filing
2026-06-30 $746k 14k 54.94
2026-03-31 $423k 13k 33.22

More positions owned by Abel Hall

Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us Small Cap Etf (DFSV)
Dimensional Etf Trust Us High Prof Etf (DUHP)
Apple (AAPL)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Dimensional Etf Trust Intl Small Cap V (DISV)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)

View all positions for Abel Hall

Top funds holding Tg Therapeutics

BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Geode Capital Management
D. E. Shaw & Co
Soleus Capital Management
ClearBridge Advisors
Congress Asset Management
Two Sigma Investments
Jane Street
Goldman Sachs Group
Susquehanna International
Pictet Asset Management Holding SA
Nuveen

View all funds holding Tg Therapeutics